Arntzen Grand Challenges Lecture Series
The Arntzen Grand Challenges Lecture series is inspired by Dr. Charles (Charlie) Arntzen, Founding Director of the ASU Biodesign Institute. Dr. Arntzen is internationally recognized for his novel applied research on the development of genetic strategies for using plants to manufacture pharmaceuticals and produce cost-effective vaccines or drugs to save lives around the world, especially in developing nations.
The Biodesign Institute seeks nature-inspired solutions to grand challenges in health, security and sustainability for global impact.
Programmable Genome Engineering Using CRISPR Technology
Thursday, Nov. 1, 2018 | Marston Exploration Theater | 4 p.m.
Samuel Sternberg, PhD
Department of Biochemistry and Molecular Biophysics
Few discoveries transform a discipline overnight, but scientists today can manipulate cells in ways hardly imaginable before, thanks to a peculiar form of adaptive immunity mediated by Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR). From elegant studies that deciphered how these immune systems function in bacteria, researchers quickly uncovered the technological potential of Cas9, an RNA-guided DNA-cleaving enzyme, for genome engineering. Today, this core capability is being harnessed for a wide variety of ambitious applications, including human therapeutics, agricultural improvement, and the elimination of certain infectious diseases. Sternberg will describe the discovery and basic function of CRISPR technology and highlight recent advances in our understanding of CRISPR biology, which continue to inspire exciting technological innovation.
This fund supports the Arntzen Grand Challenges Lecture Series with an annual visiting scientific leader who will present his or her work of global impact, connect with ASU scientists, share ideas with students, and engage with our local community. Give a gift today.